Medical product development is a regulated process requiring proactive planning. Phil has efficiently integrated documentation and submission requirements in product development activities to assure early submissions, short review times, and accelerated market introductions. All of the regulatory submissions he has authored have been cleared in times shorter than FDA review averages.
He is past President of the Intermountain Biomedical Association, current Chair of the University of Utah Department of Bioengineering's Industrial Advisory Board, and was recently inducted as a Fellow of the American Institute of Medical and Biological Engineering (AIMBE).
Phil holds M.S. and Ph.D. Degrees in Bioengineering from the University of Utah where he was a Research Fellow, and a B.S. Degree in Biomedical Engineering awarded cum laude from Rensselaer Polytechnic Institute. His master's thesis, Surface Modification and Characterization of Commonly Used Catheter Materials was conducted under the direction of Prof. Joe Andrade, and his doctoral dissertation, Release of Albumin from Biodegradable Poly(l-lactic acid) Matrices under the direction of Profs. Sung Wan Kim in the United States and Jan Feijen in the Netherlands.